South Dakota: Dupixent (dupilumab) litig… | DrugsMonitor.com

Dupixent (dupilumab) litigation in South Dakota (SD): State-level court context, limitation talking points, attorney consult—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, South Dakota